Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a Randomized Study of SCO-792 in Type 2 Diabetes with Albuminuria
jRCT1080225017Phase 2Completed
- Sponsor
- SCOHIA PHARMA, Inc.
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of Sucunamostat in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis (3 arms), sponsored by SCOHIA PHARMA, Inc. Started Jan 2020; status: completed.
02
Drugs
Sucunamostat
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on jRCT1080225017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225017.